DONGGUAN, China, Sept. 2, 2024 /PRNewswire/ — QCY, a leading brand in innovative audio solutions, introduces the Crossky C30 Clip-On Open Earbuds. This breakthrough audio wearable features an innovative C-shaped design that offers unparalleled… Read More »QCY Unveiled Crossky C30: Open-Ear Headphones with Innovative Clip-On Design
SHENZHEN, China, Sept. 2, 2024 /PRNewswire/ — In the face of rapid global technological advancements and industrial transformation, the leading event organizer, RX Greater China, will host a pivotal event, the “Six Connected Shows… Read More »Six Advanced Manufacturing Shows Unite as the RX Mega Feast of Innovation in Shenzhen This November
VoidMetrix, a top-tier platform has announced its achievements on several groundbreaking innovations in the field of financial technology. NEW YORK, NY, Sept. 02, 2024 (GLOBE NEWSWIRE) — With the latest developments, VoidMetrix announces significant technological… Read More »VoidMetrix Announces Significant Technological Advancements Poised to Transform the FinTech Landscape.
Kaizen Gaming to activate premium brand Betano and Stoiximan until 2026/27 in three-year agreement MONACO, Sept. 02, 2024 (GLOBE NEWSWIRE) — UEFA has announced Kaizen Gaming, one of the biggest GameTech companies in the world,… Read More »Betano becomes official global sponsor of UEFA Europa League and UEFA Conference League
“Hon Hai Sustainable Monitoring Platform” embodies innovative spirit at Group’s 50-year mark TAIPEI, Sept. 2, 2024 /PRNewswire/ — Hon Hai Technology Group (“Foxconn”) (TWSE:2317) today announced its proprietary platform that can intelligently track sustainability progress at… Read More »Hon Hai Technology Group (Foxconn) Wins Prestigious Red Dot Design Award For Proprietary ESG Platform
NANJING, China, Sept. 2, 2024 /PRNewswire/ — On September 02, 2024, Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group (2096.HK), announced a collaboration agreement with Shenzhen TargetRx Inc. The partnership focuses on the… Read More »Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor